Literature DB >> 22682101

Assessment of cerebral blood flow findings using 99mTc-ECD single-photon emission computed tomography in patients diagnosed with major depressive disorder.

Yuko Nagafusa1, Nagahisa Okamoto, Kota Sakamoto, Fumio Yamashita, Atushi Kawaguchi, Teruhiko Higuchi, Hiroshi Matsuda.   

Abstract

BACKGROUND: Single-photon emission computed tomography (SPECT) is used as an ancillary diagnostic tool in clinical psychiatry. A variety of SPECT studies has been conducted on the findings and the factors that affect the findings, and there is a possibility that age has an effect on cerebral blood flow. We used SPECT to verify the cerebral blood flow findings of patients with major depressive disorder (MDD) considering the effect of age on the findings.
METHODS: We conducted a retrospective survey of inpatients who fulfilled the DSM-IV diagnostic criteria for MDD and who had undergone imaging by technetium-99m ethyl cysteinate dimer ((99m)Tc-ECD) SPECT (N=98, 37 males). After excluding organic factors and comorbidities, we established a depression group (N=61, 24 males) and conducted an inter-group comparison with a normal control group by using SPM software considering the effect of age.
RESULTS: The depression group showed the reduction of cerebral blood flow in the prefrontal area bilaterally, predominantly on the left, including the orbitofrontal cortex, anterior portion of the gyrus cinguli, and dorsolateral prefrontal area, in the left temporal lobe, and in the occipital lobe bilaterally, predominantly on the left. The findings were common to all age groups and that age-specific pattern was not detected. LIMITATIONS: The facts that this was a retrospective study and small sample size in each age group were limitations of this research. Although it also seems important to evaluate the impact of medication on cerebral blood flow and conduct an evaluation according to the subtype of depression, but we couldn't in this study. In the future it will be necessary to accumulate additional cases and conduct additional studies, including a prospective survey.
CONCLUSION: The results of this study may suggest the existence of a common biological background in patients with MDD that is unaffected by age.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682101     DOI: 10.1016/j.jad.2012.03.026

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  21 in total

1.  Coverage of blood vessels by astrocytic endfeet is reduced in major depressive disorder.

Authors:  Grazyna Rajkowska; Jonathan Hughes; Craig A Stockmeier; Jose Javier Miguel-Hidalgo; Dorota Maciag
Journal:  Biol Psychiatry       Date:  2012-11-10       Impact factor: 13.382

Review 2.  Brain Photobiomodulation Therapy: a Narrative Review.

Authors:  Farzad Salehpour; Javad Mahmoudi; Farzin Kamari; Saeed Sadigh-Eteghad; Seyed Hossein Rasta; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

3.  TRPM2 Channel Aggravates CNS Inflammation and Cognitive Impairment via Activation of Microglia in Chronic Cerebral Hypoperfusion.

Authors:  Jun Miyanohara; Masashi Kakae; Kazuki Nagayasu; Takayuki Nakagawa; Yasuo Mori; Ken Arai; Hisashi Shirakawa; Shuji Kaneko
Journal:  J Neurosci       Date:  2018-03-09       Impact factor: 6.167

Review 4.  Unfolding the Role of BDNF as a Biomarker for Treatment of Depression.

Authors:  Tarapati Rana; Tapan Behl; Aayush Sehgal; Pranay Srivastava; Simona Bungau
Journal:  J Mol Neurosci       Date:  2020-11-23       Impact factor: 3.444

5.  Altered resting-state cerebral blood flow and functional connectivity mediate suicidal ideation in major depressive disorder.

Authors:  Dandan Fan; Cancan He; Xinyi Liu; Feifei Zang; Yao Zhu; Haisan Zhang; Hongxing Zhang; Zhijun Zhang; Chunming Xie
Journal:  J Cereb Blood Flow Metab       Date:  2022-03-29       Impact factor: 6.960

6.  Frequency-dependent amplitude alterations of resting-state spontaneous fluctuations in late-onset depression.

Authors:  Yingying Yue; Xize Jia; Zhenghua Hou; Yufeng Zang; Yonggui Yuan
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

7.  First-episode medication-naive major depressive disorder is associated with altered resting brain function in the affective network.

Authors:  Xiaocui Zhang; Xueling Zhu; Xiang Wang; Xiongzhao Zhu; Mingtian Zhong; Jinyao Yi; Hengyi Rao; Shuqiao Yao
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

8.  Comparison of cerebral blood flow in oral somatic delusion in patients with and without a history of depression: a comparative case series.

Authors:  Motoko Watanabe; Yojiro Umezaki; Anna Miura; Yukiko Shinohara; Tatsuya Yoshikawa; Tomomi Sakuma; Chisa Shitano; Ayano Katagiri; Miho Takenoshita; Akira Toriihara; Akihito Uezato; Toru Nishikawa; Haruhiko Motomura; Akira Toyofuku
Journal:  BMC Psychiatry       Date:  2015-03-10       Impact factor: 3.630

9.  Differences in cerebral perfusion deficits in mild traumatic brain injury and depression using single-photon emission computed tomography.

Authors:  Kristoffer Romero; Sandra E Black; Anthony Feinstein
Journal:  Front Neurol       Date:  2014-08-20       Impact factor: 4.003

10.  Improved Pre-attentive Processing With Occipital rTMS Treatment in Major Depressive Disorder Patients Revealed by MMN.

Authors:  Muzhen Guan; Xufeng Liu; Li Guo; Ruiguo Zhang; Qingrong Tan; Huaihai Wang; Huaning Wang
Journal:  Front Hum Neurosci       Date:  2021-06-08       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.